Related Experiment Videos
Diagnostic biomarkers of Alzheimer's disease in Down syndrome
1Alzheimer's Therapeutic Research Institute, Keck School of Medicine of University of Southern California, San Diego, CA 92121, USA.
The Lancet. Neurology
|September 3, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phosphorylated tau 217 in young adults with Down syndrome and Down syndrome regression disorder.
Communications medicine·2026
Cerebral microhemorrhage and cognition in preclinical Alzheimer's disease.
The journal of prevention of Alzheimer's disease·2026
Blood pressure and transcranial ultrasound predict moyamoya vasculopathy in Down syndrome.
Developmental medicine and child neurology·2026
Sex-specific biological aging clocks across organs and omics.
Nature medicine·2026
Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial.
Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Antibody-mediated encephalitides: distinct diseases with transdisciplinary implications.
The Lancet. Neurology·2026
Degenerative cervical myelopathy: early detection and the potential for preventing disability.
The Lancet. Neurology·2026
Interdisciplinary and inter-personnel issues during rapid on-site evaluation: an analysis of 2025 American Society of Cytopathology survey results.
Journal of the American Society of Cytopathology·2026
Affinity Chromatography With Selective Nucleic Acid Hybridization: Direct Coupling With Size Exclusion Chromatography.
Journal of separation science·2026
Analytical Agreement and Diagnostic Performance of a Commercial Point-of-Care Lipid Testing System for Lipid Profile and Atherogenic Ratios.
Diagnostics (Basel, Switzerland)·2026
Fully automated robotic sample preparation coupled with UPLC-MS/MS for high-throughput screening of 19 nitazene analogues in human urine.
Journal of pharmaceutical and biomedical analysis·2026